Print
A national panel of experts announced on Friday that it believes it’s safe to resume the rollout of Johnson & Johnson’s COVID-19 vaccine, a decision that comes about a week after the federal government paused its use to investigate rare cases of severe blood clots.
The Advisory Committee on Immunization Practices reviewed all available evidence on an unusual combination of blood clots and low platelet counts seen in some people who’d received the vaccine. The symptoms that resulted were severe and, in some cases, fatal. But the committee noted that these cases were extremely rare and outweighed by the benefits of vaccination. And the panel felt that the brief pause on the vaccine’s use had served one of its main purposes helping doctors recognize and treat patients.
CDC, FDA lift Johnson & Johnson vaccine pause, Bay Area may resume one-dose shots soon
FacebookTwitterEmail
1of3
Nurse Cy Martens prepares a dose of the Johnson & Johnson COVID-19 vaccine on March 11, 2021 in Oakland, California. Gabrielle Lurie / The ChronicleShow MoreShow Less
2of3
Saroeun Sim gets a bandaid over the spot where she received the Johnson & Johnson COVID-19 vaccine on Friday, March 26, 2021 in Oakland, California.Gabrielle Lurie / The ChronicleShow MoreShow Less
3of3
Mory Chhom translates for patient Lann Tuonn as she prepare to receive the Johnson & Johnson COVID-19 vaccine from nurse Anna Briggs at the Center for Empowering Refugees in collaboration with Native American Health on Friday, March 26, 2021 in Oakland, California.Gabrielle Lurie / The ChronicleShow MoreShow Less
COVID-19 FAQ Tackles Vaccines Safety and Distribution for Black and African American Californians
COVID-19 vaccinations are currently in full force, with over 20 million Californians currently having received one of the three FDA approved vaccines. President Biden recently announced vaccine eligibility expansion for all adult Americans beginning April 19, while every Californian 16 and up are eligible for vaccination on April 15.
As vaccinations continue at a notable pace, the State of California is committed to providing sufficient, transparent and comprehensive information about the safety and distribution of the COVID-19 vaccines. The below FAQ is Part II of a series of commonly asked questions and answers on vaccine safety and distribution focused on educating the Black and African American community on the safety of the vaccines and to help them understand the importance of these vaccines and their role in helping end the pandemic for all Californians.
At Least 4 Bay Area Counties Pause Use Of J&J Vaccines Amid Blood Clot Concerns postnewsgroup.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from postnewsgroup.com Daily Mail and Mail on Sunday newspapers.
OAKLAND California health officials on Tuesday announced they will stop
administering the Johnson & Johnson Covid-19 vaccine a move that comes after federal health agencies earlier in the day recommended an immediate pause after six women developed a rare and severe type of blood clot after receiving the shot.
Gov. Gavin Newsom said the pause should not affect California’s goals of opening vaccine eligibility to most people this week and broadly reopening the economy in June. The state will work to allocate Pfizer-BioNTech and Moderna shots to the roughly 8,800 people who have signed up for J&J shots, he said.